The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices

Theratechnologies Inc unchanged

Theratechnologies Inc is unchanged Thursday sitting at $7.84. Over the last five days, shares have gained 6.52% and 186.13% year to date. Shares have outperformed the S&P TSX by 197.15% during the last year.

Key company metrics

  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS-$0.14
Updated July 27 3:58 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-26.83%

Theratechnologies Inc has a net profit margin of -26.83%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX0.00%Sector:HealthcareIndustry:Pharmaceuticals - Generic & Specialty

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2017Q1/2017Q4/2016Q3/2016
Fiscal Quarter Endvalues in $ millions unless otherwise notedMay 31, 201705/31/2017Feb 28, 201702/28/2017Nov 30, 201611/30/2016Aug 31, 201608/31/2016
Revenue109109
Total other revenue--------
Total revenue109109
Gross profit8787
Total cost of revenue2222
Total operating expense15988
Selling / general / administrative8554
Research & development4212
Depreciation / amortization1010
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-5021
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-9-211
Income after tax-9-201
Income tax, total----10
Net income-9-201
Total adjustments to net income--------
Net income before extra. items-9-201
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-9-201
Inc. avail. to common incl. extra. items-9-201
Diluted net income-9-201
Dilution adjustment--------
Diluted weighted average shares73716666
Diluted EPS excluding extraordinary itemsvalue per share-0.12-0.030.000.01
Dividends per sharevalue per share0.000.00--0.00
Diluted normalized EPSvalue per share-0.12-0.030.000.01